Steven Nissen, MD, on Liraglutide

preview_player
Показать описание
The Cleveland Clinic's Chief of Cardiovascular Medicine discusses the potential dual efficacy of type 2 diabetes medication Liraglutide, when considered for cardiovascular conditions.
Рекомендации по теме